More Optiscan Imaging Limited news
Optiscan Imaging LimitedASX: OIL

Optiscan Correlates with Histology in Breast Study

Sep 19, 2023 at 12:09 AM EDT · Issued by Optiscan Imaging Limited

Filed with ASX · Sep 19, 2023 at 12:09 AM EDT

On 6ix: 6ix.com/news/optiscan-correlates-with-histology-in-breast-study

Optiscan Imaging Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Optiscan Imaging Limited on 6ix

Story so far

  • Completion of imaging for Melbourne Breast cancer trialNov 12, 2021
  • OIL breast cancer study to commence next stage - revisedFeb 8, 2021
  • Optiscan breast cancer study to commence next stageFeb 8, 2021

Earlier from Optiscan Imaging

  • OIL Appendix 4E and June 2023 Annual ReportAug 30, 2023
  • Optiscan Achieves Telepathology MilestoneAug 14, 2023
  • OIL June 2023 Quarterly Report and Appendix 4CJul 28, 2023
  • Entitlement Offer Results and Shortfall AnnouncementJul 12, 2023
  • Optiscan Launches Entitlement Offer to Raise $16.7MMay 30, 2023

Later from Optiscan Imaging

  • OIL September 2023 Quarterly Report and Appendix 4COct 31, 2023
  • Response to ASX Price QueryNov 14, 2023
  • OIL December 2023 Quarterly Report and Appendix 4CJan 30, 2024
  • Optiscan receives $3 million CRC-P Industry GrantFeb 13, 2024
  • OIL Appendix 4D and 31 December 2023 Half-year reportFeb 22, 2024
All Optiscan Imaging news releases↗

Follow Optiscan Imaging into a list and get an email when it puts out news.

Follow Optiscan Imaging
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer